Lalan Wilfong, MD

Articles by Lalan Wilfong, MD

Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model

ByBrigham Walker, PhD,Lalan Wilfong, MD,Nicholas Robert, MD,Alexander Siebert, PhD,J. Russell Hoverman, MD, PhD

June 11th 2025

A private oncology shared savings plan reduced colon cancer treatment costs. Results varied by tumor, with none in breast cancer and mixed effects in lung cancer.

ctDNA and the Enduring Role of Value-Based Models: Lalan Wilfong, MD

ByGiuliana Grossi,Lalan Wilfong, MD

May 1st 2025

Lalan Wilfong, MD, of Thyme Care and Texas Oncology, discusses a session on circulating tumor DNA (ctDNA) and shares insight as chair of the Community Oncology Alliance (COA) Payer Reform Committee.

State Legislatures Lead the Way on Policy Reform to Protect Personalized Medicine

ByAngela Storseth-Cooper,Lalan Wilfong, MD

February 22nd 2023

Practice Radiation Patterns Among Oncologists in the Oncology Care Model

ByBrigham Walker, PhD,Vivek Kavadi, MD,Lalan Wilfong, MD,Nicholas Robert, MD

October 7th 2022

Despite the potential incentives for medical oncologists to reduce radiation therapy utilization under the Oncology Care Model, we find no evidence that such reduction occurred.

Telemedicine for Cancer Care: Implementation Across a Multicenter Community Oncology Practice

ByDebra Patt, MD, MPH, MBA,Lalan Wilfong, MD,Kristen Kanipe, MD, MPH,R. Steven Paulson, MD

December 18th 2020

Texas Oncology physicians discuss utilization of telemedicine, evaluating trends, barriers, and opportunities in care delivery during the coronavirus disease 2019 pandemic.